Aditya Baid
About Aditya Baid
Data last updated:
Aditya Baid is a Director at Steril-Gene Life Sciences Private Limited (since 2026), Designated Partner at Excipients House Llp (since 2018) and Director at International Ingredients & Excipients Private Limited (since 2019), and holds 6 more current directorships. The companies operate in Pharma, Agriculture and Travel and Hospitality. The 5 current companies with reported revenue have a combined latest revenue of ₹593 Cr; the largest is Steril-Gene Life Sciences Private Limited at ₹404 Cr (FY 2025). Earlier, Aditya Baid was an Additional Director at Hindustan Chamber Of Commerce (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Steril-Gene Life Sciences Private Limited U02423TN2007PTC062549 | Director | 24 Jun 2026 | 2007 | ₹404 Cr (FY 2025) | Active |
 Excipients House Llp AAJ-1683 | Designated Partner | 07 Sep 2018 | 2017 | ₹113 Cr (FY 2024) | Active |
 International Ingredients & Excipients Private Limited U15125TN2017PTC119191 | Director | 01 Jul 2019 | 2017 | ₹41.96 Cr (FY 2025) | Active |
| Lloyd Laboratories Private Limited U24231TN2005PTC057548 | Director | 30 Sep 2011 | 2005 | ₹33.86 Cr (FY 2024) | Active |
| Dra Zen Projects Private Limited U68200TN2019PTC127695 | Additional Director | 20 Jul 2026 | 2019 | ₹19 Lakh (FY 2025) | Active |
| Mgfn Strat Llp ACT-4394 | Partner | 12 Dec 2025 | 2025 | Active | |
| Lactusa Healthcare Private Limited U21001TN2025PTC186712 | Director | 05 Dec 2025 | 2025 | Active | |
| Nutragro Farms Llp ABB-7749 | Partner | 16 Sep 2024 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hindustan Chamber Of Commerce U33111TN1947NPL000861 | Additional Director | 04 Oct 2024 | 1947 | ₹80.9 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aditya Baid
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditya Baid
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditya Baid
Aditya Baid currently holds 9 directorships: Steril-Gene Life Sciences Private Limited (Director, since 24 Jun 2026, revenue ₹404 Cr (FY 2025)); Excipients House Llp (Designated Partner, since 07 Sep 2018, revenue ₹113 Cr (FY 2024)); International Ingredients & Excipients Private Limited (Director, since 01 Jul 2019, revenue ₹41.96 Cr (FY 2025)); Lloyd Laboratories Private Limited (Director, since 30 Sep 2011, revenue ₹33.86 Cr (FY 2024)); Dra Zen Projects Private Limited (Additional Director, since 20 Jul 2026, revenue ₹19 Lakh (FY 2025)); and 4 more.
Aditya Baid was first appointed on 30 Sep 2011 as Director at Lloyd Laboratories Private Limited. The most recent appointment on record is 20 Jul 2026 at Dra Zen Projects Private Limited.
The 5 current companies of Aditya Baid that report revenue have a combined latest revenue of ₹593 Cr: Steril-Gene Life Sciences Private Limited ₹404 Cr (FY 2025); Excipients House Llp ₹113 Cr (FY 2024); International Ingredients & Excipients Private Limited ₹41.96 Cr (FY 2025); Lloyd Laboratories Private Limited ₹33.86 Cr (FY 2024); Dra Zen Projects Private Limited ₹19 Lakh (FY 2025).
Aditya Baid held 1 earlier board appointment: Hindustan Chamber Of Commerce (Additional Director, 04 Oct 2024 to 29 Sep 2025).
The current boards of Aditya Baid's companies include Alagappan (Steril-Gene Life Sciences Private Limited), Chanpreet Singh Anand (Steril-Gene Life Sciences Private Limited), Dennis Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Dick Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Lloyd Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Manohar Srivignesh (Steril-Gene Life Sciences Private Limited), among others.